Mohit Trikha

Title: Mohit Trikha: Innovator in Tumor Cell Detection

Introduction

Mohit Trikha is a notable inventor based in Grosse Pointe City, MI (US). He has made significant contributions to the field of cancer diagnostics through his innovative work on truncated integrins. With a total of 2 patents, Trikha's research focuses on the detection of tumor cells, which is crucial for early diagnosis and treatment.

Latest Patents

Trikha's latest patents include groundbreaking work on antibodies specific for soluble truncated integrins. One of his patents details the discovery of tr-&agr;IIb, a soluble, truncated integrin that is exclusively expressed in tumor cells. Additionally, he has identified another truncated integrin, tr-&bgr;3, which is also found exclusively in tumor cells. His diagnostic compositions include nucleic acid probes and antibodies that facilitate the detection of these truncated integrins, thereby identifying the presence of tumor cells in various samples.

Career Highlights

Mohit Trikha is affiliated with Wayne State University, where he continues to advance his research in the field of cancer diagnostics. His work has garnered attention for its potential to improve diagnostic accuracy and patient outcomes.

Collaborations

Trikha collaborates with Kenneth V Honn, a fellow researcher, to further enhance the impact of their findings in the medical community.

Conclusion

In summary, Mohit Trikha is a dedicated inventor whose work on truncated integrins is paving the way for innovative diagnostic methods in cancer detection. His contributions are vital for the advancement of medical science and patient care.